Méndez-Durán Antonio, Ignorosa-Luna Manuel Humberto, Pérez-Aguilar Gilberto, Rivera-Rodríguez Francisco Jesús, González-Izquierdo José Jesús, Dávila-Torres Javier
División de Hospitales, Coordinación de Áreas Médicas, Unidad de Atención Médica, Dirección de Prestaciones Médicas, Instituto Mexicano del Seguro Social, Ciudad de México, México.
Rev Med Inst Mex Seguro Soc. 2016 Sep-Oct;54(5):588-93.
The IMSS performs systematically the data updating of patients with renal replacement therapy (RRT) by an electronic record management referred as: Census patients with Chronical Renal Failure (CIRC) which aims to meet the prevalence of patients with chronic renal failure and the behavior of RRTat the IMSS.
A retrospective study includes 212 secondary hospitals with dialysis programs, with both pediatric and adult patients. CIRC data obtained from January to December 2014, number and nominal bonds of peritoneal dialysis (PD) and hemodialysis (HD). Prevalence of patients and therapies by delegation, distribution by gender and age, cause of kidney disease, morbidity and mortality were identified.
55,101 patients, of whom 29,924 were male (54 %) and 25,177 women (46 %), mean age was 62.1 years (rng: 4-90); 20,387 were pensioners (36.9 %). The causes of renal failure were: diabetes 29,054 (52.7 %), hypertension 18,975 (34.4 %), chronic glomerulopathies 3,951 (7.2 %), polycystic kidneys 1,142 (2.1 %), congenital 875 (1.6 %) and other 1,104 (2 %). HD was given in 41 % of patients, and the remaining 59 % DP; the annual cost was 5,608,290,622 pesos.
The increased prevalence of diabetes mellitus and hypertension affect the onset of RRT, which show a catastrophic financial outlook for the Institute.
墨西哥社会保障局(IMSS)通过一个名为“慢性肾衰竭患者普查(CIRC)”的电子记录管理系统,系统地对接受肾脏替代治疗(RRT)的患者数据进行更新,其目的是了解慢性肾衰竭患者的患病率以及IMSS的RRT情况。
一项回顾性研究纳入了212家设有透析项目的二级医院,涵盖儿科和成年患者。收集2014年1月至12月期间的CIRC数据、腹膜透析(PD)和血液透析(HD)的数量及名义债券。确定按地区划分的患者和治疗方法的患病率、按性别和年龄分布、肾病病因、发病率和死亡率。
共有55101名患者,其中男性29924名(54%),女性25177名(46%),平均年龄为62.1岁(范围:4 - 90岁);20387名是退休人员(36.9%)。肾衰竭的病因包括:糖尿病29054例(52.7%)、高血压18975例(34.4%)、慢性肾小球病3951例(7.2%)、多囊肾1142例(2.1%)、先天性875例(1.6%)以及其他1104例(2%)。41%的患者接受HD治疗,其余59%接受DP治疗;年度费用为5608290622比索。
糖尿病和高血压患病率的上升影响了RRT的发病情况,这对该机构而言呈现出灾难性的财务前景。